ProMeris Duo

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone / amitraz
MedicineVeterinaryWithdrawn

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

български (BG) (268.89 KB - PDF)

Rodyti

español (ES) (234.19 KB - PDF)

Rodyti

čeština (CS) (263.37 KB - PDF)

Rodyti

dansk (DA) (231.6 KB - PDF)

Rodyti

Deutsch (DE) (237.07 KB - PDF)

Rodyti

eesti (ET) (231.04 KB - PDF)

Rodyti

ελληνικά (EL) (273.19 KB - PDF)

Rodyti

français (FR) (234.85 KB - PDF)

Rodyti

italiano (IT) (230.99 KB - PDF)

Rodyti

latviešu (LV) (271.61 KB - PDF)

Rodyti

lietuvių (LT) (260.01 KB - PDF)

Rodyti

magyar (HU) (258.27 KB - PDF)

Rodyti

Malti (MT) (269.89 KB - PDF)

Rodyti

Nederlands (NL) (232.34 KB - PDF)

Rodyti

polski (PL) (261.12 KB - PDF)

Rodyti

português (PT) (233.54 KB - PDF)

Rodyti

română (RO) (259.96 KB - PDF)

Rodyti

slovenčina (SK) (264.08 KB - PDF)

Rodyti

slovenščina (SL) (250.13 KB - PDF)

Rodyti

suomi (FI) (232.08 KB - PDF)

Rodyti

svenska (SV) (233.25 KB - PDF)

Rodyti

Product information

български (BG) (555.84 KB - PDF)

Rodyti

español (ES) (463.63 KB - PDF)

Rodyti

čeština (CS) (510.99 KB - PDF)

Rodyti

dansk (DA) (459.91 KB - PDF)

Rodyti

Deutsch (DE) (565.04 KB - PDF)

Rodyti

eesti (ET) (467.29 KB - PDF)

Rodyti

ελληνικά (EL) (564.31 KB - PDF)

Rodyti

français (FR) (554.89 KB - PDF)

Rodyti

italiano (IT) (606.2 KB - PDF)

Rodyti

latviešu (LV) (595.88 KB - PDF)

Rodyti

lietuvių (LT) (529.65 KB - PDF)

Rodyti

magyar (HU) (592.54 KB - PDF)

Rodyti

Malti (MT) (547.9 KB - PDF)

Rodyti

Nederlands (NL) (466.67 KB - PDF)

Rodyti

polski (PL) (634.45 KB - PDF)

Rodyti

português (PT) (565.16 KB - PDF)

Rodyti

română (RO) (532.02 KB - PDF)

Rodyti

slovenčina (SK) (543.1 KB - PDF)

Rodyti

slovenščina (SL) (539.48 KB - PDF)

Rodyti

suomi (FI) (477.98 KB - PDF)

Rodyti

svenska (SV) (457.92 KB - PDF)

Rodyti

Íslenska (IS) (462.33 KB - PDF)

Rodyti

norsk (NO) (546.57 KB - PDF)

Rodyti
Latest procedure affecting product information:IB/0011
08/07/2015

български (BG) (197.83 KB - PDF)

Rodyti

español (ES) (145.18 KB - PDF)

Rodyti

čeština (CS) (186.36 KB - PDF)

Rodyti

dansk (DA) (145.68 KB - PDF)

Rodyti

Deutsch (DE) (154.34 KB - PDF)

Rodyti

eesti (ET) (145.19 KB - PDF)

Rodyti

ελληνικά (EL) (198.38 KB - PDF)

Rodyti

français (FR) (145.66 KB - PDF)

Rodyti

italiano (IT) (145.84 KB - PDF)

Rodyti

latviešu (LV) (199.11 KB - PDF)

Rodyti

lietuvių (LT) (184.36 KB - PDF)

Rodyti

magyar (HU) (185.85 KB - PDF)

Rodyti

Nederlands (NL) (145.6 KB - PDF)

Rodyti

polski (PL) (164.96 KB - PDF)

Rodyti

português (PT) (145.14 KB - PDF)

Rodyti

română (RO) (146.57 KB - PDF)

Rodyti

slovenčina (SK) (183.09 KB - PDF)

Rodyti

slovenščina (SL) (162.45 KB - PDF)

Rodyti

suomi (FI) (149.94 KB - PDF)

Rodyti

svenska (SV) (145.54 KB - PDF)

Rodyti

Íslenska (IS) (146.14 KB - PDF)

Rodyti

norsk (NO) (145.55 KB - PDF)

Rodyti

Product details

Name of medicine
ProMeris Duo
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AD51

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000108
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
7

Assessment history

This page was last updated on

Share this page